Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease. (2023)
Attributed to:
Interrogating ITGA11 signalling in rodent and human for targeted anti-fibrotic therapy in liver fibrosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ejendo/lvad071
PubMed Identifier: 37358209
Publication URI: http://europepmc.org/abstract/MED/37358209
Type: Journal Article/Review
Volume: 188
Parent Publication: European journal of endocrinology
Issue: 7
ISSN: 0804-4643